文献速递血栓与止血

法国前瞻性多中心研究:妊娠及产褥期静脉血栓栓塞症的流行病学

Epidemiology of venous thromboembolism during pregnancy and postpartum: results from the French prospective multicenter HEMOrrhage and venous THromboEmbolism in PostPartum study.
PubMed 文献 · J Thromb Haemost · 2026-01-29

HEMOTHEPP 前瞻性队列纳入法国 6 家产科中心 20 238 名孕妇,随访至产后 3 个月。产后 VTE 发生率为 4.9/1000 人年,高于预期;32.0% 事件发生在产后 0–7 天,60.0% 在 8–42 天;中危女性接受血栓预防与否 VTE 发生率相似。

要点

  • 产后 VTE 发生率 4.9/1000 人年,为预期的两倍。
  • 产后 8–42 天发生 60.0% 的 VTE 事件,非仅集中在产后首周。
  • 按 RCOG 评分中高危者仅 39.6% 接受血栓预防,存在处方不足。

核心结论

  • 产后 VTE 发生率高于预期,且血栓预防处方不足。
  • 产后第一周后及中危女性中 VTE 发生率仍高,无论是否接受血栓预防,提示需随机试验评估预防获益。

研究设计与样本

  • 法国 Finistère 地区 6 家产科中心的前瞻性多中心队列研究(HEMOTHEPP)。
  • 2015 年 6 月至 2019 年 1 月纳入所有 ≥16 岁、妊娠 >15 周分娩的孕妇,共 20 238 名,随访至产后 3 个月。
  • 主要结局为独立委员会裁定的症状性、有记录 VTE(DVT、PE 或非常规部位 VTE)。

主要发现

  • 产后 VTE 发生率为 4.9/1000 人年(95%CI 3.3–7.2),妊娠期为 1.3/1000 人年(95%CI 0.8–2.0)。
  • 产后 VTE 构成:40.0% 孤立性 PE,12.0% PE 合并 DVT,12.0% 孤立性 DVT,36.0% 非常规部位 VTE。
  • 产后 VTE 时间分布:32.0% 在产后 0–7 天,60.0% 在 8–42 天,8.0% 在 43–90 天。
  • 按 RCOG 风险评分,7978 名(39.5%)为中危或高危、符合血栓预防指征,其中仅 3161 名(39.6%)实际接受预防。
  • 中危女性中,接受与未接受血栓预防的 VTE 发生率相似:分别为 12.0/1000 人年与 11.8/1000 人年。

关键数值与推荐

  • 产后 VTE 发生率 4.9/1000 人年(95%CI 3.3–7.2)。
  • 妊娠期 VTE 发生率 1.3/1000 人年(95%CI 0.8–2.0)。
  • RCOG 评分中危或高危且符合血栓预防指征者占 39.5%(7978/20 238),其中接受预防者占 39.6%(3161/7978)。
  • 中危女性接受与未接受血栓预防的 VTE 发生率分别为 12.0/1000 人年与 11.8/1000 人年。

临床怎么用

  • 产后 VTE 风险持续至产后 6 周,尤其 8–42 天,应加强该时段监测。
  • 按 RCOG 评分筛出的中高危孕妇血栓预防处方率不足四成,需改进落实。
  • 中危女性血栓预防的获益尚不明确,需随机试验进一步评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Venous thromboembolism (VTE) prevention in obstetrics remains a major public health concern. Precise data on the timing of VTE events and which women are at risk are necessary to improve thromboprophylaxis strategies. OBJECTIVES: Primary objective was to determine the incidence of VTE during postpartum. Secondary objectives were: (i) to assess VTE incidence during pregnancy; (ii) to describe VTE risk factors; (iii) to evaluate VTE incidence according to risk stratification and thromboprophylaxis. METHODS: From June 2015 to January 2019, the prospective cohort "HEMOTHEPP" study included all pregnant women aged ≥16 years admitted for delivery after 15 weeks of gestation in the Finistère region of France (6 maternity units) and followed for 3 months postpartum. An ethics committee approved the study. The primary outcome was symptomatic, documented VTEs-deep vein thrombosis (DVT), pulmonary embolism (PE), or unusual site VTE-as adjudicated by an independent committee. RESULTS: Among the 20 238 included women, VTE incidence was 4.9 per 1000 person-years (95% CI, 3.3-7.2) during postpartum and 1.3 per 1000 person-years (95% CI, 0.8-2.0) during pregnancy. Postpartum VTEs included 40.0% isolated PEs, 12.0% PE with DVTs, 12.0% isolated DVTs, and 36.0% unusual site VTEs. Of these events, 32.0% occurred during days 0 to 7, 60.0% during days 8 to 42, and 8.0% during days 43 to 90 postpartum. According to the Royal College of Obstetricians and Gynaecologists risk score, 7978 women (39.5%) were classified as intermediate or high risk of postpartum VTE and eligible for thromboprophylaxis; among them, only 3161 (39.6%) received it. Among intermediate-risk women, VTE incidence was similar with or without thromboprophylaxis: 12.0 and 11.8 per 1000 person-years, respectively. CONCLUSION: Postpartum VTE incidence was twice as high as expected. Thromboprophylaxis during postpartum was underprescribed. The high VTE incidence rate after the first week postpartum and in intermediate-risk women, regardless of thromboprophylaxis, highlights the need for randomized trials to evaluate the benefits of thromboprophylaxis.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Laouenan E, Anouilh F, Courtois-Communier E, et al. Epidemiology of venous thromboembolism during pregnancy and postpartum: results from the French prospective multicenter HEMOrrhage and venous THromboEmbolism in PostPartum study. J Thromb Haemost. 2026. PMID: 41617038. doi:10.1016/j.jtha.2025.12.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。